IQVIA vs Parexel: which does AI recommend?

Since Jun 5 · · ChatGPT and Google AI Mode

Based on 68 AI responses that name bothReviewed by

How we measure

AI summary

tends to get recommended over for multi-country oncology programs, where answers cite its higher presence in European trial support.

Head to head

Listed first when AI names both

IQVIAIQVIA: 84% (IQVIA leads)ParexelParexel: 16%

Recommended when named

IQVIAIQVIA: 82%
ParexelParexel: 82%

Warned against · lower is better

IQVIAIQVIA: 9%
ParexelParexel: 9%

Topic by topic

IQVIA named more5About even1

IQVIA named more

About even1

Only IQVIA is ranked in12

Only Parexel is ranked in1

What people ask AI about IQVIA and Parexel

IQVIA listed firstParexel listed first
  1. Who are the leading contract research organizations for running oncology clinical trials in Eastern Europe?IQVIA almost always first
  2. What's the best modern CRO for a startup running its first clinical trial?IQVIA often first

Who AI mentions first

IQVIA listed firstParexel listed first
  • ChatGPTIQVIA listed first: 84%Parexel listed first: 16%

Sources AI cites

IQVIA favouredNeither favouredParexel favoured

Other brands AI mentions

BrandMentioned in
  1. ICON plc75%
  2. Medpace60%
  3. PPD47%
  4. Syneos Health41%
  5. OCT Clinical Trials40%
  6. HungaroTrial35%
  7. Thermo Fisher Scientific29%
  8. Fortrea26%
  9. Worldwide Clinical Trials22%
  10. PSI CRO21%
  11. Research Professionals (RP-CRO)19%
  12. Cromos Pharma13%

IQVIA vs Parexel: common questions

Is IQVIA better than Parexel?
IQVIA tends to get recommended over Parexel for multi-country oncology programs, where answers cite its higher presence in European trial support.
What are the alternatives to IQVIA and Parexel?
AI most often names ICON plc, Medpace, PPD and Syneos Health in the same answers.

Related comparisons

How would your brand compare?

See how your brand compares in AI answers.